These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 19145943)

  • 1. [The role of leptin in polycystic ovary syndrome].
    Marciniak A; Starczewski A
    Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polycystic ovary syndrome].
    Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome.
    Ludwig AK; Weiss JM; Tauchert S; Dietze T; Rudolf S; Diedrich K; Peters A; Oltmanns KM
    Hum Reprod; 2007 Jun; 22(6):1555-61. PubMed ID: 17395684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reproductive phenotype in polycystic ovary syndrome.
    Chang RJ
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):688-95. PubMed ID: 17893687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP; Baker TE; Baker VM; DiMarino P; Castracane VD
    Am J Obstet Gynecol; 2008 Jun; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
    Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM
    Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCOS in adolescents.
    Diamanti-Kandarakis E
    Best Pract Res Clin Obstet Gynaecol; 2010 Apr; 24(2):173-83. PubMed ID: 19932060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine characteristics of polycystic ovary syndrome (PCOS).
    Szilágyi A; Szabó I
    Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.